Targeting of the FOXM1 Oncoprotein by E3 Ligase-Assisted Degradation

Guoshun Luo1, Xin Lin1, Antonio Vega-Medina2

  • 1State Key Laboratory of Natural Medicines and Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing 211198, P. R. China.

Insights

Researchers designed a novel molecule to degrade the FOXM1 oncoprotein, a key target in cancer. This protein-targeting chimera approach shows promise for treating triple-negative breast cancer (TNBC).

Area of Science:

  • Molecular Oncology
  • Drug Discovery

Background:

  • The transcription factor FOXM1 is a crucial regulator of proliferation-related genes and an attractive target in oncology.
  • Current small-molecule inhibitors targeting FOXM1 often suffer from insufficient specificity and efficacy.

Purpose of the Study:

  • To design an effective CRBN-recruiting molecule for targeted FOXM1 protein degradation.
  • To evaluate the in vivo antitumor activity of the designed molecule against triple-negative breast cancer (TNBC) xenografts.

Main Methods:

  • Utilized in silico modeling of the FOXM1 DNA-binding domain (FOXM1-DBD) with inhibitors.
  • Developed a novel protein-targeting chimera strategy to induce FOXM1 protein degradation.

Main Results:

  • Successfully designed a CRBN-recruiting molecule that effectively degrades FOXM1 protein.
  • Demonstrated promising in vivo antitumor activity in TNBC xenograft models.

Conclusions:

  • This study pioneers the use of protein-targeting chimeras to degrade the challenging FOXM1 oncoprotein.
  • Presents a novel therapeutic strategy to counteract the oncogenic role of FOXM1 in cancer.

Related Concept Videos

Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.9K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.2K